Focused clinical development program with two flagship products formulated and registered under MDD.
More products are developed, formulated, and ready for further research and clinical trials.
Our Product pipeline is focused on therapeutic areas where we believe we have the best opportunity to deliver high quality
treatment and care with the use of cannabinoids.